ホーム > 研究交流 > A3 Foresight Program Seminar - IGCC 2011 held in April, 2011 in Seoul, Korea
A3 Foresight Program Seminar - IGCC 2011 held in April, 2011 in Seoul, Korea
NRF A3 Foresight Program Seminar - IGCC 2011
-Epigenetic Signatures in Gastric Carcinogenesis-
| Date |
April 20-24, 2011 |
| Venue |
Coex Convention Center |
Summary
The A3 Foresight Program 2011 Seminar was held together with the 9th International Gastric Cancer Congress (IGCC) on April 20-23, 2011, at Coex Convention Center, Seoul, Korea. Approximately 2,000 participants from around the world (54 countries) attended in IGCC 2011. A total of 34 scientists (14 senior and 20 junior) in the A3 Foresight Program from 3 nations also attended in this congress. Dr. Woo Ho Kim, the principal investigator of NRF A3 Foresight Program, and Dr. Han-Kwang Yang, a member of NRF A3 Foresight Program, served as a vice president and the scientific program chair of IGCC 2011, respectively. Four senior scientists talked as invited speakers in educational sessions, a symposium and a workshop in this congress. Eight senior scientists from 3 nations also talked their current findings by oral presentation in the A3 Foresight Program sessions. There are 757 poster presentations in IGCC 2011 and 20 young scientists from A3 Foresight Program participated in this poster session. It is noteworthy that Dr. Hyang Sook Seol (Korea) and Dr. Sohachi Nanjo (Japan) won the Best Poster Award in this session. A lot of scientists in IGCC 2011 attended our oral and poster presentations in A3 foresight Program. It was a very good chance for us to talk and discuss about our current researches in an international meeting. Among 3 nations, we discussed about collaborative researches in the business meeting, which was held on April 22. Thus, these A3 seminar and IGCC 2011 in Korea were very fruitful for both junior and senior scientists to promote their researches further.
Program
April 21 (Thr)
Educational
lectures |
Toshikazu Ushijima (National Cancer Center Research Institute, Japan): Aberrant DNA methylation and gastric cancer
Shu Shimada (Tokyo Medical and Dental University, Japan): Mouse model of diffuse-type gastric cancer by conditional inactivation of E-cadherin and p53
|
NRF A3 Foresight Program (oral presentation)
Chairpersons:
Dae Hee Kang and
Yoshimitsu Akiyama |
Yoshimitsu Akiyama (Tokyo Medical and Dental University, Japan): Epigenetic alterations of GATA4 and GATA5 transcription factors in gastric cancers
Yong Sung Kim (Korea Research Institute of Bioscience and Biotechnology, Korea): Epigenomic signature during intestinal-type gastric carcinogenesis
Se Jin Jang (Asan Medical Center, Korea): MicroRNA mediated transcriptional gene silencing and DNA methylation in RASSF1A gene
Wei-Guo Zhu (Peking University Health Science Center, China): Methyltransferase Set7/9 regulates p53 activity by interacting with SIRT1 |
Chairpersons:
Dajun Deng and
Yong Sung Kim |
Gyeong Hoon Kang (Seoul National University, Korea): Methylation changes of repetitive DNA elements in gastric carcinoma and premalignant lesions and their clinical implications
Hiroshi Fukamachi (Tokyo Medical and Dental University, Japan): Identification of tumor-initiating cells in human gastric cancers
Kai-feng Pan (Peking University Cancer Hospital and Institute, China): Cox-2 methylation/expression, H. pylori infection, and evolution of precancerous gastric lesions: results from an intervention trial
Dae Hee Kang (Seoul National University, Korea): Epigenetic profiling in cardia and noncardia gastric cancer |
April 22 (Fri)
NRF A3 Foresight Program (poster session)
Chairpersons:
Hiroshi Fukamachi
and Se Jin Jang |
So Huyn Shin (Seoul National University College of Medicine, Korea): Genome-wide high throughput analysis for promoter methylation in gastric cancer identifies novel methylation markers
Jin Kim (Seoul National University College of Medicine, Korea): Genome-wide DNA methylation analysis in human gastric carcinoma
Yantao Du (Peking University Cancer Hospital and Institute, China): Methylation profiling of miRNA CpG islands in the development of human gastric carcinomas
So Hyun Shin (Seoul National University College of Medicine, Korea): Identification of novel methylation markers in gastric cancer using pharmacological genomic unmasking
Keeok Haam (Korea Research Institute of Bioscience and Biotechnology, Korea): Demethylation on DNMT3L 5’ UTR in intestinal-type gastric tumor detected by RRBS analysis
Bo Tu (Peking University Health Science Center, Peking University, China): Histone acetyltransferase Tip60 interacts with histone methyltransferase SUV39H1 to regulate gene expression
Jong-Lyul Park (Korea Medical Genomics Research Center, KRIBB, Korea): Comparison between 5-mC and 5-hmc genomic distribution in a gastric cancer cell based on NGS technology
Fuzheng Wei (Peking University Health Science Center, Peking University, China): HDAC inhibitor depsipeptide cooperates with 5-aza-2’-deoxycytidine to increase the accessibility of chromatin
Hui-juan Su (Peking University Cancer Hospital & Institute, China): Association between genetic variants in microRNA-related genes and risk of gastric cancer and its precursors
Ji Eun Yu (Seoul National University College of Medicine, Korea): Oncogenic effect of microRNA-222/221 transgenic mouse in gastric cancer |
Chairpersons:
Yoshimitsu Akiyama
and
Gyeong Hoon Kang |
Pichayanoot Rotkrua (Tokyo Medical and Dental University, Japan): MIR-9 down-regulates CDX2 expression in gastric cancer cells
Hyang Sook Seol (Asan Medical Center, University of Ulsan College of Medicine, Korea): Primary culture of tumorigenic cells from human gastric, colonic and lung cancers for the identification of epigenetic signature in cancer stem cells
Yutaka Hashimoto (Tokyo Medical and Dental University, Japan): Up-regulation of miRNAs by treatment with the chromatin-modifying drugs and identification of common target genes in gastric cancer cells
Yanhong Gao (Peking University Cancer Hospital and Institute, China): Inactivation of ZNF382 by hypermethylation defending metastasis of primary gastric carcinomas
Zhaojun Liu (Shanghai Jiao-Tong University School of Medicine, China): STAT3 represses E-cadherin and induces EMT progression via activation of DNMT1 and ZEB1 in colon carcinogenesis
Sohachi Nanjo(National Cancer Center Research Institute, Japan): Isolation of epigenetic gastric cancer risk markers not influenced by current Helicobacter pylori infection
Hyuna Sung (Graduate School of Seoul National University, Korea): Differential expression and regulation of epigenetic markers in gastric cancer
Jin Kim (Seoul National University College of Medicine, Korea): Aberrant DNA methylation and tumor suppressive activity of the EBF3 gene in gastric carcinoma
Ming-yang Song (Beijing Cancer Hospital & Institute, China): Microarray-based screening of serum microRNA biomarkers for early detection of gastric cancer
Wenyu Su (Shanghai Jiao-Tong University School of Medicine, Ren-Ji Hospital, China): The role of Morg1 and DHPS in gastric tumor |
| Symposium |
Dajun Deng (Peking University Cancer Hospital and Institute, China): DNA methylation markers as predictors of initiation and progression of gastric carcinomas
|
Business meeting of NRF A3 Foresight Program
Group Discussion on Collaborative Research Themes
| R-1 |
Risk factors of GC accounting for host epigenetic alterations among three nations |
| R-2 |
Investigation of mechanisms of gene-specific silencing of tumor-suppressor genes during gastric carcinogenesis |
| R-3 |
DNA methylome and its applications on subtyping of gastric carcinomas |
| R-4 |
Epigenetic changes in GC stem cells |
April 23 (Sat)
| Workshop |
Wei-cheng You (Peking University Cancer Hospital and Institute, China): A large trial to prevent gastric cancer in Linqu, China
|
Photographs of Dr. Hyang Sook Seol (left) and Dr. Sohachi Nanjo (right) who won Best Poster Awards in IGCC 2011
